The importance of using core outcome measures during therapeutic studies of eosinophilic esophagitis - 03/02/22
Key words : Eosinophilic esophagitis, clinical trial, core outcomes set
Il testo completo di questo articolo è disponibile in PDF.
Research in the Hill Lab is funded by the National Institutes of Health (grants DK116668, DK129418, and AI045008), Children’s Hospital of Philadelphia Research Institute, American Academy of Allergy, Asthma & Immunology, American Partnership for Eosinophilic Disorders, and the Food Allergy Fund. The views expressed in this editorial are those of the author and do not represent the official views of the National Institutes of Health or other funders. |
|
Disclosure of potential conflict of interest: The author declares that he has no relevant conflicts of interest. |
Vol 149 - N° 2
P. 541-542 - Febbraio 2022 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?